The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 10.00 (3.92%)
Spread: 10.00 (3.846%)
Open: 255.00
High: 265.00
Low: 255.00
Prev. Close: 255.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Sep 2017 15:30

RNS Number : 4787R
Anpario PLC
21 September 2017
 

Anpario plc

("Anpario" or the "Company")

Director/PDMR Shareholding

Anpario announces that on 20 September 2017 Karen Prior, Finance Director (the "Director") of the Company sold interests in ordinary shares of 23p each in the Company ("Ordinary Shares") as set out in the table below. These interests, as joint beneficial owner, were held on the terms of joint ownership agreements entered into in September 2011 under the Company's Joint Share Ownership Plan ("JSOP") which had become fully vested. The disposal was effected by the exercise of conversion options requiring the co-owner (the plan trustee) to exchange tranches of their respective interests so that the Director acquires a beneficial interest in a whole number of shares equal in value to the gain accrued under the terms of the JSOP award. The Director immediately sold in the market such number of shares in the Company at a price per share of £3.80 per Ordinary Share.

Name of Director

No. of jointly owned Ordinary Shares

No. of Ordinary Shares acquired on exercise of exchange

No. of Ordinary Shares Sold

Karen Prior

175,000

125,018

125,018

 

The remaining 49,982 Ordinary Shares formerly held in joint ownership have been acquired by RBC cees Limited as trustee of The Anpario plc Group Employees' Share Trust (the "Trustee") (the "Trust") pursuant to the exercise of the conversion options by the Trustee in its capacity as co-owner.

Ordinary Shares issued under the Company's JSOP

Anpario also announces that, on 20 September 2017, it has allotted 125,018 new Ordinary Shares. The Ordinary Shares have been issued at a subscription price of £3.75 per Ordinary Share, being the closing price of an Ordinary Shares on 19 September 2017, pursuant to The Anpario plc Employees' JSOP (the "Plan").

The Ordinary Shares have been issued into the respective joint beneficial ownership of (i) the participating executive Director, Karen Prior and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director, the Company and the Trustee. The subscription price has been paid by the Trust out of funds advanced to it by the Company.

In addition, 49,982 existing Ordinary Shares, which as previously described had been acquired by the Trustee on the exercise of conversion options in respect of shares formerly held in joint ownership, have been transferred by the Trustee, for no consideration, into the respective joint beneficial ownership of (i) each of the participating executive Directors named below and (ii) the Trustee upon and subject to the terms of the JOAs respectively entered into between the Director concerned, the Company and the Trustee. 

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the initial market value (£3.75 pence per share), less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost. Jointly owned Ordinary Shares will become vested if the participant remains with the Company for a minimum period of 3 years. 

 

 

 

 

 

Effect of the transactions

Following the above transactions, the beneficial interests held by Karen Prior will be as follows:

Jointly Owned 23p Ordinary Shares:

Existing interests in jointly owned Ordinary Shares

Jointly owned Ordinary Shares acquired and sold under the JSOP

Jointly owned Ordinary Shares transferred to the Trustee under the JSOP

 

Interests in jointly owned Ordinary Shares transferred from the Trustee to Directors under the JSOP

New interests in jointly owned Ordinary Shares issued under JSOP

Remaining interests in jointly owned Ordinary Shares

1,200,000

(125,018)

(49,982)

49,982

125,018

1,200,000

 

Beneficially Owned 23p Ordinary Shares: 202,836

Share Options:

EMI 122,400

SAYE 4,015

 

Application for Ordinary Shares

Application for admission to AIM has also been separately made in relation to 125,018 Ordinary Shares, and it is expected that admission will be effective on 27 September 2017.

The Company's issued share capital following the admission of the Ordinary Shares will comprise 23,261,362 Ordinary Shares with voting rights. The Company holds 143,042 Ordinary Shares in Treasury. The total number of ordinary shares in issue (excluding shares held as treasury shares) is 23,118,320 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Karen Prior

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Purchase of ordinary shares of 23 pence each in the Company ("Ordinary Shares")

 

ISIN GB00B3NWT17

b)

Nature of the transaction

 

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

380p

125,018

d)

Aggregated information

 

Price(s)

Volume(s)

380p

125,018

e)

Date of the transaction

 

2017-09-20

f)

Place of the transaction

 

 

London Stock Exchange (XLON), AIM

 

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer +44 (0) 791 955 2040

 

Peel Hunt LLP

Adrian Trimmings +44 (0) 207 418 8900

George Sellar

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGZLDMNGNZM
Date   Source Headline
5th May 20223:18 pmRNSHolding(s) in Company
4th May 20221:14 pmRNSTotal Voting Rights
28th Apr 202211:17 amRNSHolding(s) in Company
20th Apr 20221:49 pmRNSHolding(s) in Company
19th Apr 20223:47 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSDirectorate Change
6th Apr 202210:10 amRNSHolding(s) in Company
6th Apr 202210:09 amRNSTotal Voting Rights
1st Apr 20223:41 pmRNSHolding(s) in Company
25th Mar 202210:40 amRNSHolding(s) in Company
24th Mar 202212:57 pmRNSGrant of share awards
22nd Mar 20225:08 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results
8th Mar 20222:35 pmRNSBlock listing Interim Review
8th Mar 20222:34 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFull Year Trading Statement
3rd Dec 20217:00 amRNSUK patent granted for Orego-stim
18th Nov 20211:17 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSNew Commitment to Sustainable Operations
3rd Nov 202112:04 pmRNSTotal Voting Rights
1st Nov 202110:03 amRNSHolding(s) in Company
26th Oct 20214:28 pmRNSHolding(s) in Company
12th Oct 20217:20 amRNSDirector/PDMR Shareholding
15th Sep 202111:51 amRNSHalf-year Report - Replacement
15th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20219:52 amRNSTotal Voting Rights
20th Jul 20219:42 amRNSBlock listing Interim Review
9th Jul 20212:16 pmRNSAnpario receives “Community Business Hero Award"
17th Jun 20211:24 pmRNSResult of AGM
17th Jun 20217:00 amRNSAGM Statement
7th Jun 20213:58 pmRNSDirector/PDMR Shareholding
24th May 20219:48 amRNSHolding(s) in Company
18th May 20217:00 amRNSNotice of AGM
4th May 20214:16 pmRNSDirector/PDMR Shareholding
4th May 20214:10 pmRNSTotal Voting Rights
28th Apr 20214:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20214:05 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSBoard update
13th Apr 20219:17 amRNSHolding(s) in Company
13th Apr 20219:17 amRNSHolding(s) in Company
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.